Fate therapeutics announces first patient treated in first-in-human clinical trial of ft596 and provides corporate update

San diego, april 02, 2020 (globe newswire) -- fate therapeutics, inc. (nasdaq: fate), a clinical-stage biopharmaceutical company dedicated to the...

FATE Ratings Summary

FATE Quant Ranking